INDUCTION OF FIBRINOLYSIS BY HYPERVENTILATION WITH OXYGEN AND CARBON DIOXIDE
- Blood relation. Heptinstall, Stan // Nature;10/1/1992, Vol. 359 Issue 6394, p447
Reviews the periodical `Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis,` edited by J.L. Francis and S.G. Gordon.
- Current Drug Treatment Strategies for Disseminated Intravascular Coagulation. de Jonge, E.; Levi, M.; Stoutenbeek, C.P.; van deventer, S.J.H. // Drugs;Jun1998, Vol. 55 Issue 6, p767
Disseminated intravascular coagulation (DIC) can be caused by a variety of diseases. Experimental models of DIC have provided substantial insight into the pathogenesis of this disorder, which may ultimately result in improved treatment. Disseminated coagulation is the result of a complex...
- The role of ultrasonography and inferior vena cava filter... Headrick, James R.; Barker, Donald E. // American Surgeon;Jan1997, Vol. 63 Issue 1, p1
States that undetected lower-extremity deep-vein thrombosis (LEDVT) in the trauma patient can lead to significant morbidity and morality. Evaluation of the role of ultrasonography in the early detection of LEDVT in high-risk trauma patients; Identification of prognostic indicators that predict...
- phlebitis. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p606
An encyclopedia entry for "phlebitis" is presented. It refers to the inflammation of a vein resulting in the development of a clot. This condition is also termed thrombophlebitis.
- Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury. Schultz, M. J.; Determann, R. M.; Royakkers, A. A. N. M.; Wolthuis, E. K.; Korevaar, J. C.; Levi, M. M. // Critical Care Research & Practice;2012, p1
Background and Objective. Bronchoalveolar coagulopathy is a characteristic feature of pulmonary inflammation. We compared bronchoalveolar and systemic levels of coagulation in patients who did and patients who did not develop ventilator-associated lung injury (VALI). Methods. Secondary analysis...
- The Involvement of Blood Coagulation Factor XIII in Fibrinolysis and Thrombosis. Muszbek, L.; Bagoly, Z.; Bereczky, Z.; Katona, É. // Cardiovascular & Hematological Agents in Medicinal Chemistry;2008, Vol. 6 Issue 3, p190
It has been known for a long time that blood coagulation factor XIII (FXIII) is essential for maintaining haemostasis, its deficiency leads to severe bleeding complication. Biochemical studies have revealed that FXIII is a key regulator of fibrinolysis and, in addition to its role in...
- Idiopathic Intracranial Hypertension: Associations with Thrombophilia and Hypofibrinolysis in Men. Glueck, Charles J.; Goldenberg, Naila; Golnik, Karl; Sieve, Luann; Ping Wang // Clinical & Applied Thrombosis/Hemostasis;Oct2005, Vol. 11 Issue 4, p441
The existence of an association between idiopathic intracranial hypertension (IIH) and coagulation disorders in men was assessed prospectively. Microthrombi, associated with thrombophilia-hypofibrinolysis, occlude arachnoid sinus villi, thus reducing resorption of cerebrospinal fluid, leading to...
- Plasma Levels of Thrombin-Activatable Fibrinolysis Inhibitor in Primary and Secondary Thrombocytosis. Kaftan, O.; Balcik, O. S.; Cipil, H.; Ozet, G.; Bavbek, N.; Koşsar, A.; Dagdas, S. // Clinical & Applied Thrombosis/Hemostasis;Oct2005, Vol. 11 Issue 4, p449
An elevated platelet count is a common finding in both hospitalized and ambulatory patients. Thrombosis and bleeding complications are more frequently observed in patients with clonal thrombocytosis than secondary thrombocytosis. The aim of this study was to investigate the behaviors of...
- Association Between Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels and Activated Protein C in Normotensive Type 2 Diabetic Patients. Yano, Yutaka; Gabazza, Esteban C.; Hori, Yasuko; Kitagawa, Nagako; Katsuki, Akira; Araki-Sasaki, Rika; Sumida, Yasuhiro; Adachi, Yukihiko // Diabetes Care;Jul2002, Vol. 25 Issue 7, p1245
Presents a letter to the editor regarding the association between plasma thrombin-activatable fibrinolysis inhibitor levels and activated protein C in normotensive type 2 diabetic patients.